HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Johanna Weiss Selected Research

pheophorbide a

11/2015Obatoclax as a perpetrator in drug-drug interactions and its efficacy in multidrug resistance cell lines.
12/2014Interaction potential of the multitargeted receptor tyrosine kinase inhibitor dovitinib with drug transporters and drug metabolising enzymes assessed in vitro.
5/2013Potential of the novel antiretroviral drug rilpivirine to modulate the expression and function of drug transporters and drug-metabolising enzymes in vitro.
4/2011Potential of novel antiretrovirals to modulate expression and function of drug transporters in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Johanna Weiss Research Topics

Disease

25Breast Neoplasms (Breast Cancer)
02/2022 - 09/2005
20Neoplasms (Cancer)
03/2022 - 04/2010
7Infections
04/2019 - 05/2007
7Squamous Cell Carcinoma of Head and Neck
01/2018 - 07/2011
5Multiple Myeloma
01/2019 - 06/2014
4COVID-19
04/2021 - 06/2020
4Pulmonary Arterial Hypertension
02/2015 - 01/2013
3Drug-Related Side Effects and Adverse Reactions
01/2014 - 03/2004
2Inflammation (Inflammations)
01/2021 - 03/2003
2Oropharyngeal Neoplasms
10/2019 - 01/2018
2Body Weight (Weight, Body)
04/2019 - 04/2014
2Dyslipidemias (Dyslipidemia)
01/2019 - 01/2004
2Prostatic Neoplasms (Prostate Cancer)
12/2017 - 10/2011
2Morbid Obesity
06/2017 - 01/2017
2Colorectal Neoplasms (Colorectal Cancer)
11/2015 - 12/2009
2Leukemia
10/2012 - 10/2006
2Hypertension (High Blood Pressure)
07/2010 - 03/2003
1Ependymoma
09/2021
1Rheumatoid Arthritis
01/2021
1Psoriasis (Pustulosis Palmaris et Plantaris)
01/2021
1Malaria
09/2020
1Autoimmune Diseases (Autoimmune Disease)
09/2020
1Invasive Fungal Infections
04/2019
1Atrial Fibrillation
01/2019
1Hemorrhage
01/2019
1Hemorrhagic Stroke
01/2019
1Stroke (Strokes)
01/2019
1Ischemic Stroke
01/2019
1Embolism (Embolus)
01/2019

Drug/Important Bio-Agent (IBA)

29Proteins (Proteins, Gene)FDA Link
02/2022 - 09/2005
24Pharmaceutical PreparationsIBA
03/2022 - 01/2008
22Member 1 Subfamily B ATP Binding Cassette TransporterIBA
07/2021 - 09/2005
10Peptides (Polypeptides)IBA
02/2022 - 01/2012
8ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2019 - 09/2005
7AnionsIBA
02/2022 - 05/2013
6EnzymesIBA
04/2019 - 01/2012
5Cytochrome P-450 CYP3AIBA
02/2022 - 02/2015
5multidrug resistance-associated protein 1IBA
02/2019 - 09/2005
5Bortezomib (Velcade)FDA Link
01/2019 - 06/2014
5Messenger RNA (mRNA)IBA
08/2015 - 11/2010
4Cytochrome P-450 CYP2C19IBA
02/2022 - 08/2006
4Pregnane X ReceptorIBA
10/2019 - 05/2013
4Voriconazole (Vfend)FDA LinkGeneric
04/2019 - 08/2006
4Bosentan (Tracleer)FDA Link
01/2019 - 06/2011
4pheophorbide aIBA
11/2015 - 04/2011
4fluorexon (calcein)IBA
11/2015 - 04/2011
4Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
11/2015 - 01/2004
4Fluorouracil (Carac)FDA LinkGeneric
04/2014 - 12/2009
4Cytostatic AgentsIBA
04/2012 - 12/2009
3Multidrug Resistance-Associated ProteinsIBA
02/2019 - 09/2005
3IsoenzymesIBA
11/2015 - 01/2004
3ambrisentanFDA Link
02/2015 - 06/2011
3Endothelin A ReceptorIBA
02/2015 - 01/2013
3Cisplatin (Platino)FDA LinkGeneric
04/2014 - 07/2011
2Cytochrome P-450 CYP2D6 (CYP2D6)IBA
02/2022 - 08/2014
2Organic Anion TransportersIBA
04/2021 - 09/2020
2Cytochrome P-450 CYP1A2 (CYP1A2)IBA
09/2020 - 08/2015
2Hydroxychloroquine (Plaquenil)FDA LinkGeneric
09/2020 - 06/2020
2Phytoestrogens (Phytoestrogen)IBA
02/2019 - 01/2016
2GenisteinIBA
02/2019 - 01/2016
2Endothelin Receptors (Endothelin Receptor)IBA
01/2019 - 10/2011
2Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
01/2019 - 01/2018
2Fluorescent Dyes (Fluorescent Probes)IBA
01/2018 - 02/2016
2Fentanyl (Sublimaze)FDA LinkGeneric
06/2017 - 01/2017
2Transcription Factors (Transcription Factor)IBA
01/2017 - 11/2015
2obatoclaxIBA
11/2015 - 11/2015
2Multidrug Resistance-Associated Protein 2IBA
02/2015 - 04/2011
2Proteasome InhibitorsIBA
02/2015 - 06/2014
2Paclitaxel (Taxol)FDA LinkGeneric
04/2014 - 07/2011
2Telmisartan (Micardis)FDA Link
01/2014 - 07/2010
2CholesterolIBA
03/2013 - 10/2007
2LipidsIBA
03/2013 - 10/2007
2Oxaliplatin (Eloxatin)FDA LinkGeneric
04/2012 - 12/2009
2Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2012 - 01/2003
2Reverse Transcriptase InhibitorsIBA
03/2011 - 05/2007
2Adenosine Triphosphate (ATP)IBA
10/2007 - 09/2005
1Amino Acid Transport Systems (Amino Acid Transporter)IBA
03/2022
1Large Neutral Amino Acid-Transporter 1IBA
03/2022
1Ketoconazole (Nizoral)FDA LinkGeneric
02/2022
1Dactinomycin (Actinomycin)FDA LinkGeneric
09/2021
1camostatIBA
04/2021
1Serine Proteases (Serine Protease)IBA
04/2021
14-(4-guanidinobenzoyloxy)phenylacetic acidIBA
04/2021
1NF-kappa B (NF-kB)IBA
01/2021
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
09/2020
1Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
09/2020
1Pantoprazole (Protonix)FDA LinkGeneric
06/2020
1Anti-Bacterial Agents (Antibiotics)IBA
04/2019
1IsoflavonesIBA
02/2019
1daidzeinIBA
02/2019
1EquolIBA
02/2019
1AnticoagulantsIBA
01/2019
1Melphalan (Alkeran)FDA LinkGeneric
01/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2019
1GlucocorticoidsIBA
01/2019

Therapy/Procedure

9Drug Therapy (Chemotherapy)
01/2016 - 09/2005
8Therapeutics
04/2019 - 03/2004
2Bariatric Surgery
06/2017 - 01/2017
2TP protocol
04/2014 - 05/2013
1Intravenous Administration
04/2019